Biphenotypic Leukemia
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies (NCT02991898) | Masonic Cancer Center, University of Minnesota | 2017-02-16 |
| Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT (NCT01012492) | Boston Children's Hospital | 2009-11-01 |
| A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies (NCT01036009) | University of California, San Francisco | 2009-10-01 |
| Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies (NCT00908167) | St. Jude Children's Research Hospital | 2009-09-01 |
| Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy (NCT00606216) | Memorial Sloan Kettering Cancer Center | 2007-01-01 |
Track Biphenotypic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.